Sponsor Pipeline

Arvinas Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-06 NCT07749586 A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced… Phase 1/2 Recruiting
Active Trials by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07749586 A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced… Advanced Solid Tumor Recruiting
NCT07023731 A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation KRAS G12D Mutation Active, Not Recruiting
Phase 1
NCT06393738 A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) Recruiting
Disease Areas
Non-Hodgkin Lymphoma (1)
Get alerts when Arvinas Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free